|
Mr. Brodeur, age 53, has over 25 years of senior financial leadership in healthcare, medical device, biotechnology and clinical laboratory industries. From December 2005 to August 2007, Mr. Brodeur was a Managing Partner at Prairieview CFO Partners, LLP, a CFO services firm serving public or pre-IPO emerging, middle-market businesses. From September 2004 to December 2005, Mr. Brodeur served as the Chief Financial Officer of McKesson Medication Management, Inc., a pharmacy outsource provider to acute care hospitals. From December 2001 to March 2004, Mr. Brodeur was a Senior Partner at Tatum CFO Partners, LLP, a national CFO services firm serving emerging, middle-market and multinational companies. Through Tatum CFO Partners, Mr. Brodeur served as Chief Financial Officer of Molecular Diagnostics, Inc. and Aastrom Biosciences, Inc., publicly traded medical device companies. Mr. Brodeur has also served as Chief Financial Officer of Meris Laboratories, Inc. and held senior financial leadership positions with EPS Solutions Corporation and WellPoint Health Networks Inc. Mr. Brodeur is a certified public accountant who began his career at Ernst & Young. | 